News

GlobalData on MSN7h
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
Fierce Biotech2d
FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
WKTV NewsChannel 22h
FDA Greenlights First Blood Test to Help Diagnose Alzheimer’s Disease in the US
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
US FDA clears first blood test for Alzheimer's detection
The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...
Richmond Times-Dispatch4h
FDA OKs first blood test that can help diagnose Alzheimer's disease
The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...
BioSpace4h
FDA Clears First Alzheimer’s Blood Test, Lending ‘Momentum’ to Lilly’s Kisunla, Biogen’s Leqembi
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
Honolulu Star-Advertiser2d
FDA clears first blood test for Alzheimer’s detection
The Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, the regulator ...
STAT2h
Some scientists are getting their NIH research dollars back
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
FDA clears 1st blood test to help diagnose Alzheimer's disease
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
The American Journal of Managed Care1h
FDA Clears First Blood Test for Early Detection of Alzheimer-Linked Amyloid Plaques
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
US FDA clears first blood test to detect Alzheimer's disease
The U.S. Food and Drug Administration said on Friday it has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's ...
Business Wire10d
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s ...
--(BUSINESS WIRE)--Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. announced the completion of a prospective sample acquisition as part of ...